Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy

OBJECTIVES: To define fatigue trajectories in patients with rheumatoid arthritis (RA) who initiate biological DMARD (bDMARD) treatment, and explore baseline predictors for a trajectory of continued fatigue. METHODS: One-hundred and eighty-four patients with RA initiating bDMARDs were assessed at 0,...

Descripción completa

Detalles Bibliográficos
Autores principales: Provan, Sella Aarrestad, Michelsen, Brigitte, Sexton, Joseph, Uhlig, Tillmann, Hammer, Hilde Berner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856128/
https://www.ncbi.nlm.nih.gov/pubmed/33214326
http://dx.doi.org/10.1136/rmdopen-2020-001372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856128/
https://www.ncbi.nlm.nih.gov/pubmed/33214326
http://dx.doi.org/10.1136/rmdopen-2020-001372

Ejemplares similares